Entrepreneurs

Seven more companies, most of them start ups, have been qualified by the state Department of Commerce for the state's Angel Investor and Venture Fund Tax Credit programs. Under the programs, people who invest in these companies are eligible for state tax credits. ...

Tommy Thompson, two days after launching a presidential bid, is positioning himself as the "idea candidate" of the 2008 presidential race. At the recent Wisconsin Biotechnology and Medical Device Association annual conference, he outlined a few suggestions to speed the pace of electronic health record...

Complementary product lines and exposure to new clients were the motivation for Eagle Technology of Mequon to acquire the Knoxville, Tenn.-based Equipsoft Corp. Eagle, which operates in a mature industry with more then 300 competitors, is looking to expand its client base beyond asset management. ...

The decline in IT program enrollments across the state is attributed largely to young people being scared away by the dotcom bust, but now that the technology sectors are bouncing back, what is being done to grow the future IT labor force? In this look...

Nerites Corp. is conducting animal tests to validate two new products, and it recently raised an additional $1 million to support its business operations. The money, which was raised from angel investors, brings the company's venture capital base to $3 million. ...

The new products and solutions of 67 companies were on display during the recent DEMOfall 2006 event, raising the bar for the Winter 2007 conference. In this brief edition of DEMO Letter, columnist Chris Shipley points readers to recaps of the event's media coverage, to...

The role of Wisconsin businesses in avian flu preparedness and genetic-based medicine will be among the trends explored at the 2006 Wisconsin Biotechnology and Medical Device Association conference. The annual gathering, which will convene Oct. 12 at the GE Healthcare Institute, will feature addresses by...

NimbleGen Systems, Inc., has improved its ability to sell microarray products to researchers worldwide by obtaining a non-exclusive, worldwide license to a number of patents held by Affymetrix, Inc. Affymetrix, which is based in Santa Clara, Calif., developed the first commercial microarray in 1994. ...